Kamal Tabti

8PUBLICATIONS
28CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 27, 2024
Efficient Synthesis, Structural Characterization, Antibacterial Assessment, ADME-Tox Analysis, Molecular Docking and Molecular Dynamics Simulations of New Functionalized Isoxazoles.

Aziz Arzine, Hanine Hadni, Khalid Boujdi

|Dec 07, 2023
QSAR-driven screening uncovers and designs novel pyrimidine-4,6-diamine derivatives as potent JAK3 inhibitors.

Abdelmoujoud Faris, Ibrahim M Ibrahim, Radwan Alnajjar

|Oct 20, 2023
In silico computational drug discovery: a Monte Carlo approach for developing a novel JAK3 inhibitors.

Abdelmoujoud Faris, Ivana Cacciatore, Ibrahim M Ibrahim

|Jun 20, 2023
In silico discovery of potent and selective Janus kinase 3 (JAK3) inhibitors through 3D-QSAR, covalent docking, ADMET analysis, molecular dynamics simulations, and binding free energy of pyrazolopyrimidine derivatives.

Abdelmoujoud Faris, Hanine Hadni, Ibrahim M Ibrahim

|Jun 15, 2023
In silico screening of a series of 1,6-disubstituted 1H-pyrazolo[3,4-d]pyrimidines as potential selective inhibitors of the Janus kinase 3.

Abdelmoujoud Faris, Hanine Hadni, Basil A Saleh

|Dec 19, 2022
Discovery of anti-colon cancer agents targeting wild-type and mutant p53 using computer-aided drug design.

Hanine Hadni, Menana Elhallaoui

Pageof 2

Frequent Collaborators

4 joint publications

Abdelmoujoud Faris

3 joint publications

Ibrahim M Ibrahim

1 joint publications

Basil A Saleh

1 joint publications

Hadjer Khelfaoui